Financial Ratios

SHREE PACETRONIX LTD.

NSE : NABSE : 527005ISIN CODE : INE847D01010Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE190.004.1 (+2.21 %)
PREV CLOSE ( ) 185.90
OPEN PRICE ( ) 188.00
BID PRICE (QTY) 189.00 (100)
OFFER PRICE (QTY) 190.00 (98)
VOLUME 3644
TODAY'S LOW / HIGH ( )182.10 191.00
52 WK LOW / HIGH ( ) 96.2391.9
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)9.021.810.510.770.39
   CEPS(Rs)10.773.191.932.171.44
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)27.2218.1916.3815.8715.11
   Tax Rate(%)29.3626.3140.8633.3441.91
Margin Ratios
   Core EBITDA Margin(%)26.9117.7214.6914.1710.36
   EBIT Margin(%)24.2312.968.598.867.47
   Pre Tax Margin(%)22.779.804.104.723.34
   PAT Margin (%)16.087.222.433.141.94
   Cash Profit Margin (%)19.2012.749.178.937.12
Performance Ratios
   ROA(%)23.075.831.772.791.54
   ROE(%)39.7410.483.164.942.63
   ROCE(%)45.7612.957.649.276.80
   Asset Turnover(x)1.430.810.730.890.79
   Sales/Fixed Asset(x)1.700.800.700.860.75
   Working Capital/Sales(x)3.622.772.773.603.01
Efficiency Ratios
   Fixed Capital/Sales(x)0.591.251.431.161.33
   Receivable days101.23186.34191.30145.18156.35
   Inventory Days41.9973.1395.4289.73114.52
   Payable days20.2228.9857.7242.4238.41
Valuation Parameters
   PER(x)10.8211.2322.690.0032.82
   PCE(x)9.066.376.010.008.95
   Price/Book(x)3.591.120.710.000.85
   Yield(%)0.000.000.000.00
   EV/Net Sales(x)1.811.070.820.661.00
   EV/Core EBITDA(x)6.605.785.364.537.89
   EV/EBIT(x)7.458.239.567.4813.36
   EV/CE(x)2.240.810.590.570.76
   M Cap / Sales1.740.810.550.000.64
Growth Ratio
   Net Sales Growth(%)123.7319.40-13.7120.5610.12
   Core EBITDA Growth(%)231.2343.88-9.6939.5214.08
   EBIT Growth(%)318.4080.15-16.3842.9230.30
   PAT Growth(%)398.02255.31-33.3895.2984.81
   EPS Growth(%)398.02255.30-33.3795.2884.85
Financial Stability Ratios
   Total Debt/Equity(x)0.220.440.460.460.54
   Current Ratio(x)1.871.671.641.561.64
   Quick Ratio(x)1.401.331.181.101.03
   Interest Cover(x)16.554.111.922.141.81
   Total Debt/Mcap(x)0.060.390.660.64

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.